REGISTERED
on 13 Feb 2024
Last Applicant/ Owned by
161 Oyster Point Blvd
South San Francisco
CA
94080
Serial Number
90700876 filed on 10th May 2021
Registration Number
7305215 registered on 13th Feb 2024
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
SYNTHETIC BIOPSY
Medical services for prevention of diseases in humans based on technology focused on triggering the expression or activation in the human body of a biomarker, compound or body response usable for these medical services; Medical services for detection of diseases in humans based on technology focused on triggering the expression or activation in the human body of a biomarker, compound or body respo Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical services for prevention of diseases in humans based on technology focused on triggering the expression or activation in the human body of a biomarker, compound or body response usable for these medical services; Medical services for detection of diseases in humans based on technology focused on triggering the expression or activation in the human body of a biomarker, compound or body response usable for these medical services; Medical services for localization of diseases in humans based on technology focused on triggering the expression or activation in the human body of a biomarker, compound or body response usable for these medical services; Medical services for therapy of diseases in humans based on technology focused on triggering the expression or activation in the human body of a biomarker, compound or body response usable for these medical services; Medical services for prevention of diseases in animals based on technology focused on triggering the expression or activation in the animal body of a biomarker, compound or body response usable for these medical services; Medical services for detection of diseases in animals based on technology focused on triggering the expression or activation in the animal body of a biomarker, compound or body response usable for these medical services; Medical services for localization of diseases in animals based on technology focused on triggering the expression or activation in the animal body of a biomarker, compound or body response usable for these medical services; Medical services for therapy of diseases in animals based on technology focused on triggering the expression or activation in the animal body of a biomarker, compound or body response usable for these medical services
First Use Date in General
11th Nov 2022
First Use Date in Commerce
11th Nov 2022
Class [005]
Pharmaceutical Products
Medical products for human use that trigger expression or activation in the human body of a biomarker, compound or body response useable for prevention of diseases, namely, cancer or other diseases related to genetic dysregulation; Medical products for human use that trigger expression or activation in the human body of a biomarker, compound or body response useable for detection of diseases, namely, cancer or other diseases related to genetic dysregulation; Medical products for human use that trigger expression or activation in the human body of a biomarker, compound or body response useable for localization of diseases, namely, cancer or other diseases related to genetic dysregulation; Medical products for human use that trigger expression or activation in the human body of a biomarker, compound or body response useable for therapy of diseases, namely, cancer or other diseases related to genetic dysregulation; Medical products for animal use that trigger expression or activation in the animal body of a biomarker, compound or body response useable for prevention of diseases, namely, cancer or other diseases related to genetic dysregulation; Medical products for animal use that trigger expression or activation in the animal body of a biomarker, compound or body response useable for detection of diseases, namely, cancer or other diseases related to genetic dysregulation; Medical products for animal use that trigger expression or activation in the animal body of a biomarker, compound or body response useable for localization of diseases, namely, cancer or other diseases related to genetic dysregulation; Medical products for animal use that trigger expression or activation in the animal body of a biomarker, compound or body response useable for therapy of diseases, namely, cancer or other diseases related to genetic dysregulation
First Use Date in General
04th Jan 2023
First Use Date in Commerce
24th Jan 2023
Specimens
Mark Details
Serial Number
No 90700876
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Feb 2024 | REGISTERED-PRINCIPAL REGISTER |
| 13th Feb 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 10th Jan 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 09th Jan 2024 | ASSIGNED TO LIE |
| 09th Jan 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 09th Jan 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 09th Jan 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 15th Aug 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 07th Jul 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 07th Jul 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |